For Patients: Important Information About GLP-1 Injectable Medications
GLP-1 medications, such as Semaglutide (Wegovy) and Tirzepatide (Mounjaro), are injectable treatments used for weight management and diabetes control. These drugs work by slowing digestion, reducing appetite, and helping regulate blood sugar.
Prescribing Status
Currently, GLP-1 prescribing is not commissioned in all areas, and our practice is not commissioned to prescribe these medications. This means we are unable to provide GLP-1 treatments unless a specific contract or service agreement is in place.
For more information, you can refer to the official guidance from Wessex LMCs:
wessexlmcs.com/guidance/injectable-weight-loss-drugs
Important Information for Women Taking GLP-1 Injectable Medications
GLP-1 drugs can slow down digestion and affect the absorption of oral medications, including:
Hormone Replacement Therapy (HRT)
Oral contraceptives (the pill)
This may reduce how well these hormonal treatments work, leading to:
Increased risk of unintended pregnancy if using oral contraceptives.
Changes in hormone levels affecting HRT, potentially causing symptoms like irregular bleeding.
Recommendations for Women
Use additional or alternative contraception methods (e.g., condoms, IUDs) while taking GLP-1 medications.
Inform your healthcare provider if you are on HRT so your treatment can be reviewed and adjusted if needed.
Report any unusual symptoms such as breakthrough bleeding or hormonal changes promptly.
If you have questions or concerns about how GLP-1 treatments may affect your hormonal therapy, please contact us or your healthcare provider for advice.